Pages that link to "Q48731924"
Jump to navigation
Jump to search
The following pages link to Epilepsy and attention deficit hyperactivity disorder: Is methylphenidate safe and effective? (Q48731924):
Displaying 50 items.
- Utility of the Electroencephalogram in Attention Deficit Hyperactivity Disorder (Q22241782) (← links)
- Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges (Q26765320) (← links)
- Speed and complexity characterize attention problems in children with localization-related epilepsy. (Q27312356) (← links)
- Stimulant drugs (Q28141748) (← links)
- Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents (Q28282770) (← links)
- Management of stimulant medications in children with attention-deficit/hyperactivity disorder (Q33778188) (← links)
- Comparing stimulant effects in youth with ADHD symptoms and epilepsy (Q33944635) (← links)
- Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy (Q33987476) (← links)
- Attention deficit hyperactivity disorder (ADHD) in childhood epilepsy (Q34163795) (← links)
- Methylphenidate treatment of attention deficit hyperactivity disorder in young people with learning disability and difficult-to-treat epilepsy: evidence of clinical benefit (Q34402618) (← links)
- European guidelines on managing adverse effects of medication for ADHD. (Q34448884) (← links)
- Childhood epilepsy in relation to mental handicap and behavioural disorders (Q34540188) (← links)
- Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy (Q34553650) (← links)
- Psychostimulants and epilepsy (Q34570603) (← links)
- Methylphenidate treatment (Q34626119) (← links)
- Psychiatric comorbidity in patients with developmental disorders and epilepsy: a practical approach to its diagnosis and treatment (Q35074484) (← links)
- Neuropsychiatric aspects of epilepsy in children (Q35107808) (← links)
- Learning and behavior in children with epilepsy (Q35107813) (← links)
- Attention-deficit/hyperactivity disorder in children and adolescents: interventions for a complex costly clinical conundrum (Q35559397) (← links)
- Differential diagnosis and treatment of psychiatric disorders in children and adolescents with epilepsy (Q35879793) (← links)
- The challenge of neuropsychiatric issues in pediatric epilepsy (Q35939575) (← links)
- Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder (Q36453293) (← links)
- Role of electroencephalography in attention-deficit hyperactivity disorder (Q36492366) (← links)
- Treatment of attention deficit hyperactivity disorder in children and adolescents: safety considerations (Q36694580) (← links)
- Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment (Q37027023) (← links)
- An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy (Q37038995) (← links)
- Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management. (Q37085902) (← links)
- Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs (Q37301587) (← links)
- [Formula: see text]Differences in memory functioning between children with attention-deficit/hyperactivity disorder and/or focal epilepsy (Q37312006) (← links)
- Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities (Q37505713) (← links)
- Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex (Q37608840) (← links)
- Attention deficit and hyperactivity disorder in people with epilepsy: diagnosis and implications to the treatment (Q37719289) (← links)
- Treatment of epilepsy in children with developmental disabilities (Q37803574) (← links)
- Efficacy and safety of methylphenidate in treating ADHD symptoms in children and adolescents with uncontrolled seizures: A Brazilian sample study and literature review (Q37869621) (← links)
- Psychiatric symptomatologies and disorders related to epilepsy and antiepileptic medications (Q37880900) (← links)
- Attention and executive functions in children with epilepsy: what, why, and what to do. (Q38190121) (← links)
- Methylphenidate, cognition, and epilepsy: A double-blind, placebo-controlled, single-dose study (Q38383007) (← links)
- Management of psychiatric and neurological comorbidities in epilepsy (Q38702125) (← links)
- Methylphenidate improves learning impairments and hyperthermia-induced seizures caused by an Scn1a mutation (Q40195437) (← links)
- Recurrent absence status epilepticus (spike-and-wave stupor) associated with lamotrigine therapy. (Q40470080) (← links)
- Methylphenidate improves the quality of life of children and adolescents with ADHD and difficult-to-treat epilepsies (Q40977767) (← links)
- Regarding adult ADHD (Q42272494) (← links)
- The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies (Q42691389) (← links)
- Treating children with attention-deficit/hyperactivity disorder and comorbid epilepsy (Q42736779) (← links)
- General anesthesia in a juvenile with attention-deficit hyperactivity disorder accompanied by long-term use of methylphenidate (Concerta). (Q43218316) (← links)
- Association between attention-deficit/hyperactivity disorder and epilepsy in pediatric populations (Q43232951) (← links)
- Bupropion-methylphenidate combination and grand mal seizures (Q44208350) (← links)
- Waived EEG diagnosis before administration and during drug therapy with methylphenidate: dangerous or justifiable? (Q44243733) (← links)
- European clinical guidelines for hyperkinetic disorder -- first upgrade (Q45025898) (← links)
- The acute effect of methylphenidate in Brazilian male children and adolescents with ADHD: a randomized clinical trial (Q46413570) (← links)